New heart stent under observation in 1,100 patients
NCT ID NCT06841510
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is tracking over 1,100 people with coronary artery disease who received the GENOSS SES stent, a device that props open blocked heart arteries. Researchers are monitoring heart-related deaths, heart attacks, and the need for repeat procedures over time. The goal is to see how well the stent works in real-world use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- GENOSS SES (a drug-eluting stent)
- What this could lead to
- If successful, this could confirm that the GENOSS SES stent is a safe and effective option for treating blocked heart arteries.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be less definitive. Stents carry risks like blood clots or re-narrowing of the artery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERIAL DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul National University Bundang Hospital
Seongnam, 13620, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?